Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?

BACKGROUND: Germline pathogenic variants mutations) in the BRCA1 and BRCA2 genes cause an increased risk of breast cancer and ovarian cancer. Mainstream cancer genetic testing (MCG) was introduced for breast cancer patients in our unit in 2013. Non-geneticist clinicians have been trained to offer ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ain, Quratul, Richardson, Caroline, Mutebi, Miriam, George, Angela, Kemp, Zoe, Rusby, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982265/
https://www.ncbi.nlm.nih.gov/pubmed/36577271
http://dx.doi.org/10.1016/j.breast.2022.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982265/
https://www.ncbi.nlm.nih.gov/pubmed/36577271
http://dx.doi.org/10.1016/j.breast.2022.12.001

Ejemplares similares